被默沙东“卡脖子”,智飞生物活路在哪?

医深观
07 Feb

近日,全球疫苗巨头默沙东宣布将暂停向中国供应HPV疫苗佳达修(Gardasil)。受整体市场环境、消费者需求疲软及渠道库存高等因素影响,默沙东与本土合作伙伴智飞生物进行了深入沟通后作出的决定,本次停供至少会持续至2025年年中。而在这背后是智飞生物扛不住了的事实。01扛不住的智飞此前,智飞生物作为默沙东的独家代理商,依靠代理默沙东的HPV疫苗,营收一路狂飙,由2017年13.43亿元一路狂奔至...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10